Cargando…
Residues remote from the binding pocket control the antagonist selectivity towards the corticotropin-releasing factor receptor-1
The corticotropin releasing factors receptor-1 and receptor-2 (CRF(1)R and CRF(2)R) are therapeutic targets for treating neurological diseases. Antagonists targeting CRF(1)R have been developed for the potential treatment of anxiety disorders and alcohol addiction. It has been found that antagonists...
Autores principales: | Sun, Xianqiang, Cheng, Jianxin, Wang, Xu, Tang, Yun, Ågren, Hans, Tu, Yaoquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308710/ https://www.ncbi.nlm.nih.gov/pubmed/25628267 http://dx.doi.org/10.1038/srep08066 |
Ejemplares similares
-
Molecular switches of the κ opioid receptor triggered by 6′-GNTI and 5′-GNTI
por: Cheng, Jianxin, et al.
Publicado: (2016) -
Corticotropin-releasing Hormone and Its Biological Diversity toward Angiogenesis
por: Im, Eunok
Publicado: (2014) -
Organization of the corticotropin‐releasing hormone and corticotropin‐releasing hormone‐binding protein systems in the central nervous system of the sea lamprey Petromyzon marinus
por: Sobrido‐Cameán, Daniel, et al.
Publicado: (2022) -
Defining the role of corticotropin releasing factor binding protein in alcohol consumption
por: Haass-Koffler, C L, et al.
Publicado: (2016) -
Computational studies of DNA sequencing with solid-state nanopores: key issues and future prospects
por: Liang, Lijun, et al.
Publicado: (2014)